Medical News

RSS

IRIN examines debate over malaria control versus eradication

After the recent publication of the Lancet series on malaria eradication, IRIN examines the debate over control versus eradication, stating the findings of some of the studies.

2 Nov 2010

Fat filling for facial rejuvenation

Aging will affect all of us. Fillers are most commonly used to fill the deep lines around the mouth. Dr. Hardaway, a prominent Farmington Hills, Michigan plastic surgeon states that many patients now prefer to have their own fat injected to fill those unwanted wrinkles.

2 Nov 2010

X-BODY receives research grant for therapeutic project against metastatic tumor stem cells

X-BODY BioSciences, a developer of human monoclonal antibody therapeutics, today announced it has been awarded a research grant under the Patient Protection and Affordable Care Act of 2010 for its human monoclonal antibody therapeutic project targeting metastatic tumor stem cells.

2 Nov 2010

Study finds invasive patterns of lung cancer in pediatric patients

Because primary lung adenocarcinoma is exceedingly rare in the pediatric population, it is difficult to properly classify certain lung tumors in children and adolescents. While anecdotal reports of pediatric patients with lung cancer lesions exist, little research has been conducted to link the disease in children to similar pulmonary malignancies in adults.

2 Nov 2010

Media outlets look ahead to Obama's trip to India

Several media outlets looked ahead to President Barack Obama's scheduled visit to India later this week, as part of his Asia-Pacific tour.

2 Nov 2010

MedCath completes sale of Heart Hospital of Austin to St. David's Healthcare Partnership

MedCath Corporation and its physician partners announced today the completion of the sale of substantially all the assets of Heart Hospital of Austin to St. David's Healthcare Partnership, L.P. The transaction, which was announced in February and was subject to customary closing conditions and regulatory requirements, was completed today.

2 Nov 2010

PharmaTrust signs agreement with Sagamok community to provide MedCentre

PharmaTrust has signed the first agreement of its kind to provide a MedCentre to a First Nation community in northern Ontario. In a signing ceremony on October 29th the Sagamok Anishnawbek First Nation community finalized an agreement with PharmaTrust for the deployment of a MedCentre, which will give the community the option of convenient 24/7 access to pharmacy services.

2 Nov 2010

FDA approves Medtronic Talent Thoracic Stent Graft with Captivia Delivery System

Advancing the minimally invasive treatment of aortic aneurysms, Medtronic, Inc. (NYSE: MDT), today announced approval by the U.S. Food and Drug Administration (FDA) of the Talent Thoracic Stent Graft with Captivia® Delivery System, which features a tip capture mechanism for controlled deployment and precise placement of the implantable medical device.

2 Nov 2010

New findings pave way to improve early detection of ovarian cancer

A drug in testing to treat atherosclerosis significantly inhibited growth of ovarian cancer in both human cell lines and mouse models, the first such report of a peptide being used to fight malignancies, according to a study by researchers at UCLA's Jonsson Comprehensive Cancer Center.

2 Nov 2010

3 states to vote on health insurance mandate

Kaiser Health News staff writer Aimee Miles reports: "Voters in Arizona, Colorado and Oklahoma will have the chance Tuesday to repudiate the new health care law's keystone provision, one that requires almost everyone to have health insurance or face a tax penalty beginning in 2014" (Miles, 10/30).

2 Nov 2010

Non-dividing cells can also start cancer

Cancer Research UK scientists have found that non-dividing cells are able to kick-start some cancers, challenging a long held belief that only dividing cells, like stem cells, cause the disease, according to research published online in PNAS today (Monday).

2 Nov 2010

Races make final health overhaul messages clear as Election Day nears

Candidates push their final messages for Tuesday's elections, while the congressional debate over the health care overhaul still reverberates.

2 Nov 2010

Thomson Reuters launches Pharmacy Xpert dashboard to manage medication therapy

Thomson Reuters, a global provider of information for healthcare professionals, today announced the launch of Thomson Reuters Pharmacy Xpert the first-of-its-kind clinical intelligence dashboard that helps hospital pharmacists better manage medication therapy to improve outcomes, reduce costs, and manage risk.

2 Nov 2010

Access Pharmaceuticals receives $1.5 million in government grants

ACCESS PHARMACEUTICALS, INC. a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, announced it has been awarded $1.5 million in government grants.

2 Nov 2010

H. pylori infection reduces severity of Salmonella-induced colitis: Research

Helicobacter pylori, a common stomach bacterium, reduced the severity of inflammation of the colon caused by Salmonella in mice, according to research from U-M Medical School scientists.

2 Nov 2010

Health law, elections trigger questions about Medicare payment issues

While most people are focused on the midterm elections Tuesday, the American Medical Association is gearing up for the lame-duck congressional session scheduled to start Nov. 15.

2 Nov 2010

National Jewish Health's chronic urticaria diagnostic assay receives US patent

National Jewish Health has received a US patent for a method of detecting autoimmune chronic urticaria, which will help assure many patients that dramatic changes in lifestyle are not needed to treat the condition.

2 Nov 2010

PAREXEL first quarter revenue increases 13.9% to $295.8 million

PAREXEL International Corporation today announced its financial results for the first quarter ended September 30, 2010.

From Parexel 2 Nov 2010

NICE to lose its power to ban life saving drugs

Ministers have finally clarified that patients would not be denied life-extending drugs just because the NHS rationing body decides they are too expensive. National Institute for Health and Clinical Excellence (NICE) the drug watchdog in the UK will be stripped of its powers to stop drugs being available on the NHS due to price. The arbitrary limit on the cost of new drugs – around £30,000 per year of extended high-quality life – will be scrapped from 2014.

1 Nov 2010

XXXXL suits now on the racks: UK health experts concerned

In a worrying development Britain’s largest ‘off-the-peg’ suit - the XXXXL - has gone on sale, boasting a 64 inch chest jacket and 60 inch waist trousers. Health experts fear the development and say that a record 5.5 million overweight Britons are now officially on GP registers with an eight percent rise over last year.

1 Nov 2010